Intervention to Improve Driving Practices Among High-Risk Teen Drivers
Launched by GINGER YANG · Mar 19, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to improve driving habits among teens who have recently received a traffic violation. Researchers want to see if using a special technology in cars that provides real-time feedback about driving behavior can help reduce risky actions, like speeding or sudden stops. Additionally, the study will explore whether training for parents on how to communicate effectively with their teens about driving can make a difference.
To participate, teens aged 16-17 who have received a moving violation and hold a valid driver's license from Ohio may be eligible. They need to have access to a car made after 1996 that can connect to the feedback technology and must also have a smartphone with Bluetooth. Participants can expect to use the driving feedback system and possibly attend parent training sessions, all aimed at helping them become safer drivers. This study is currently recruiting participants, and it's an opportunity for families to work together on improving driving safety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 16-17 years at time of violation
- • Convicted of a moving violation
- • Possess a valid intermediate driver's license issued by the state of Ohio, with proof of car insurance
- • Access to a vehicle with an On-board Diagnostics II system port (i.e. cars made after 1996) in which he/she is the primary driver
- • Smartphone with Bluetooth capabilities
- • At least one legal guardian
- Exclusion Criteria:
- • Unable to drive due to injury, license suspension, or car damage
- • Vehicle already has an in-vehicle driving feedback system installed
- • Extremely low average weekly drive time (e.g. \<1 hour per week)
- • Currently enrolled in another driving-related study
- • War of the State
- • Non-English speaking parent
- • Adults unable to consent
- • Pregnant women
- • Prisoners
About Ginger Yang
Ginger Yang is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic interventions, Ginger Yang collaborates with leading healthcare institutions and research organizations to conduct rigorous clinical trials. The organization prioritizes patient safety, ethical research practices, and scientific integrity, ensuring that all studies contribute meaningful insights to the medical community. By leveraging cutting-edge methodologies and fostering partnerships, Ginger Yang aims to bring transformative treatments to market, ultimately enhancing patient care and outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbus, Ohio, United States
Patients applied
Trial Officials
Jingzhen (Ginger) Yang, PhD, MPH
Principal Investigator
Nationwide Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials